DMDiana Matheoud

Diana Matheoud

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Diana Matheoud has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Jo Anne Stratton

    Department of Neurology and Neurosurgery, Montreal Neurological Institute-Hospital, McGill University, Montreal, Canada

    2 shared publications
  • Louis-Eric Trudeau

    Department of Pharmacology and Physiology, Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada

    2 shared publications
  • Abigail Ralph

    Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, MD, USA, 20815

    1 shared publication
  • Adam MacDonald

    Montreal Neurological Institute-Hospital, McGill University

    1 shared publication
  • Alex Tchung

    Department of Pharmacology and Physiology, Faculty of Medicine, Université de Montréal, Canada; Department of Neurosciences, Faculty of Medicine, Université de Montréal, Canada; Neural Signaling and Circuitry Research Group (SNC), Canada; Center for Interdisciplinary Research on the Brain and Learning (CIRCA), Canada; Institut Courtois d'Innovation Biomédicale (CI2B), Montréal, QC H3C 3J7, Canada

    1 shared publication
  • Alexandra Kazanova

    Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada

    1 shared publication

Latest Publications

  • Peripheral Immunological Signatures of Parkinsonism: Insights from the Caribbean vs. North America

    by Hugo Chaumont, Perrine Coquelet, Renaud Balthazard, Benoit Tressières, Juliette Quéau-Chaumont, Sylvie Ravion, Stanie Gaëte, Ariane Veilleux Carpentier, Antoine Duquette, Lovatiana Andriamboavonjy, et al.

    The contribution of the peripheral immune system to Parkinson's disease (PD) and Atypical parkinsonism (AP), including multiple system atrophy, progressive supranuclear palsy, and Caribbean atypical parkinsonism, is increasingly recognized, albeit incompletely resolved. Our study aimed to compare the peripheral immunological profile of PD and AP patients from two distinct geographical areas, Guadeloupe and Montreal. We conducted a cross-sectional study on PD and AP patients and healthy controls from Guadeloupe and Montreal (total 57 subjects). We collected clinical assessments and arbovirus serologies. We performed an immune profiling of peripheral blood mononuclear cells by flow cytometry. Nearly all Guadeloupe subjects had prior exposure to an endemic arbovirus, while seropositivity was minimal in Montreal. Samples from the Guadeloupe cohort showed an increased proportion of γδ T cells and enhanced CD8+ T cell inflammatory properties, particularly in PD patients and healthy controls, compared to their Montreal counterparts. Specific memory B cell subsets were more abundant in Guadeloupe-PD and Guadeloupe-AP than in Montreal patients. The percentage of plasmablasts positively correlated with clinical scores in Guadeloupe-PD and AP patient groups. Montreal-AP patients displayed elevated monocyte percentages; proportions of monocytes and classical monocytes correlated with clinical scores in this patient group. Our study highlights immune differences related to disease type (PD vs. AP) and geographical location (Guadeloupe vs. Montreal), particularly in AP patients. A better understanding of the impact of environmental factors and age-related changes on the peripheral immune system of PD and AP patients could provide essential information to slow down and treat these conditions. Graphical Abstract The alternative text for this image may have been generated using AI.

  • Open Access

    PINK1 deficiency rewires early immune responses in a mouse model of Parkinson’s disease triggered by intestinal infection

    by Sherilyn Junelle Recinto, Alexandra Kazanova, Lin Liu, Brendan Cordeiro, Shobina Premachandran, Hicham Bessaiah, Alexis Allot, Elia Afanasiev, Sriparna Mukherjee, Jessica Pei, et al.

    Parkinson’s disease is characterized by a period of non-motor symptoms, including gastrointestinal dysfunction, preceding motor deficits by several years to decades. This long prodrome is suggestive of peripheral immunity involvement in the initiation of disease. We previously developed a model system in PINK1 KO mice displaying PD-like motor symptoms at late stages following intestinal infections. Herein, we map the initiating immune events at the site of infection in this model. Using single-cell RNAseq, we demonstrate that peripheral myeloid cells are the earliest highly dysregulated immune cell type followed by an aberrant T cell response shortly after. We also demonstrate an increased propensity for antigen presentation and that activated myeloid cells acquire a proinflammatory profile capable of inducing cytotoxic T cell responses. Together, our study provides the first evidence that PINK1 is a key regulator of immune functions in the gut underlying early PD-related disease mechanisms.


  • Open Access

    Mitochondrial antigen-specific CD8⁺ T cells drive dopamine neuron neurodegeneration

    by Moustafa N Elemeery, Alex Tchung, Salix Boulet S, Nicolas Giguère, Sarah Mezrag, Jean-Francois Daudelin, Amandine Even, Abigail Ralph, Sriparna Mukherjee, Claudie Beaulieu, et al.

    Summary: The progressive degeneration of dopamine (DA) neurons drives motor symptoms in Parkinson’s disease (PD). Whether this neuronal degeneration is due to cell-autonomous dysfunctions in DA neurons or to death signals generated by other cell types is a key problem to address. Recent evidence suggests that loss of function of the protein PINK1, linked to early-onset forms of PD, enhances the presentation of self-derived mitochondrial antigens, which induces the response of autoreactive CD8 + T cells. Whether mitochondrial antigen-specific CD8 + T cells alone are sufficient to induce nigrostriatal dysfunction has not been directly tested. Here we performed adoptive transfer of mitochondrial antigen-specific CD8 + T cells into wild-type or PINK1-deficient mice. We provide evidence for the entry and persistence of such cells in the brain and show that this leads to levodopa-reversible motor dysfunctions and partial degeneration of the nigrostriatal DA system in both genotypes. These findings establish that brain entry of autoreactive CD8 + T cells is sufficient to drive nigrostriatal degeneration and parkinsonian motor deficits, providing the most direct support to date for the hypothesis that an adaptive immune attack plays a key role in PD-like neurodegeneration.